metformin hydrochloride 500 mg tablet
PMV-586-106
Phase 1 small_molecule active
Quick answer
metformin hydrochloride 500 mg tablet for TP53 Y220C Mutation is a Phase 1 program (small_molecule) at PMV Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Program details
- Company
- PMV Pharmaceuticals
- Indication
- TP53 Y220C Mutation
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- active